Related Experiment Video For cytoreductive surgery
Updated: Sep 16, 2025

Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens
Published on: December 9, 2022
Diagnostic Pitfalls in Peritoneal Carcinomatosis: A Case of Pseudomyxoma Peritonei
Maksim Isachanka1, Ilya Tarasau2, Olga Matylevich2
1Internal Medicine, St. Elizabeth's Medical Center, Boston, USA.
Abstract:
Pseudomyxoma peritonei (PMP) is a rare pathological condition posing significant diagnostic and management challenges. This article presents a clinical case of a 58-year-old female who was initially diagnosed with stage III primary peritoneal carcinoma. Following neoadjuvant chemotherapy, a diagnostic re-evaluation was performed with histopathological and immunohistochemical review of biopsy specimens, which led to a revised diagnosis of mucinous carcinoma with features consistent with PMP. The patient subsequently underwent complete cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC). She has remained disease-free for 12 months post-operatively. This case illustrates the crucial role of pathological assessment in guiding treatment for PMP and demonstrates favorable long-term outcomes with aggressive CRS and HIPEC in appropriately selected patients.
More Related Videos
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...

